Radiology Business

SEPTEMBER 20, 2023

Backers include societies representing radiologists and nuclear medicine professionals, device manufacturers, patient advocacy groups, and pharmaceutical companies.

Nuclear Medicine 105

Nuclear Medicine Pharmaceutical Diagnostic Imaging Diagnostic 105

Imaging Technology

JULY 9, 2024

Campione also joins the Blue Earth Diagnostics Ltd. Board of Directors and will serve as Vice Chair of the Blue Earth Diagnostics Inc. Board of Directors and will serve as Vice Chair of the Blue Earth Diagnostics Inc. Blue Earth Diagnostics, an indirect subsidiary of Bracco Imaging S.p.A., Board of Directors.

Diagnostic 105

Diagnostic Radiopharmaceuticals Nuclear Medicine Magnetic Resonance Imaging 105

AuntMinnie

JULY 11, 2023

Pharmaceutical industry companies were involved in payments to diagnostic radiolog.

Diagnostic 40

Diagnostic Radiation Oncology Pharmaceutical Medicare 40

AuntMinnie

MARCH 5, 2024

Telix Pharmaceuticals has entered an agreement to acquire Canadian diagnostic imaging isotopes company ARTMS for $82 million. The companies have been collaborating since 2020 to develop higher curie-scale production of Illuccix, a PET radiotracer injection kit used for prostate cancer imaging.

Pharmaceutical 52

Pharmaceutical Diagnostic Imaging Diagnostic Imaging 52

Diagnostic Imaging

JULY 5, 2023

The prospective multicenter trial, which is slated to begin patient recruitment in late 2023, will reportedly assess the ability of 64Cu SAR-bisPSMA to diagnose prostate cancer within pelvic lymph nodes.

Pharmaceutical 57

Pharmaceutical Diagnose 57

Imaging Technology

JANUARY 8, 2024

GE HealthCare expects to leverage MIM Software’s imaging analytics and digital workflow capabilities across various care areas to accelerate innovation and differentiate its solutions for the benefit of patients and healthcare systems around the world.

Healthcare 105

Healthcare Healthcare Radiation Oncology Radiation 105

AuntMinnie

JULY 12, 2024

As nuclear medicine therapies gain stature compared to nuclear medicine in diagnostic imaging, hospital administrators may be eyeing the potential of adding theranostics services. At the time, their cancer center served a significant cancer population in the region and maintained robust and ever-expanding PET diagnostics.

Nuclear Medicine 105

Nuclear Medicine Radiation Oncology Radiopharmaceuticals Radiation 105